We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
An image displaying a Newsletter on tablet, laptop & mobile

To continue reading this article, sign up for FREE to

Technology Networks logo


Membership is FREE and provides you with instant access to email newsletters, digital publications, our full content catalogue & more...

USDM, DocuSign to Help Life Sciences Organizations Go Fully Digital

Read time: 1 minute

DocuSign, Inc. and USDM Life Sciences announced a new partnership to help organizations automate regulated business processes for dramatic ROI, increased security and compliance, and faster speed to market. DocuSign offers the industry’s only 21 CFR Part 11 compliant Digital Transaction Management (DTM) platform for easily, safely and securely managing transactions in the cloud, including clinical trials, electronic batch records, regulatory filings, training, change control, field service reports, recall notifications, laboratory procedures and more.

 “USDM is pleased to have partnered with DocuSign as the global standard for Digital Transaction Management to expand our Validation Accelerator Pack (VAP) and Cloud Assurance solution,” says Kim Hutchings, Vice President of Alliances at USDM Life Sciences.  “Our joint solution brings together USDM’s 10 plus years of VAP experience in the cloud with the power of DocuSign’s DM platform so our customers have an easy to implement, easy to validate solution that accelerates speed to market while meeting critical 21 CFR Part 11 requirements.”

With DocuSign, life science companies can easily, safely and securely manage regulated business processes including clinical trials, electronic batch records, regulatory filings, training, change control, field service reports, recall notifications, and laboratory procedures. 

“Our partnership with USDM gives life sciences organizations further confidence to go fully digital with DocuSign as the catalyst for their digital transformation,” said Neil Hudspith, chief revenue officer, DocuSign. “Now life sciences companies can manage all aspects of GxP regulated business processes in the cloud with DocuSign to eliminate paper to accelerate approval times, reduce errors and cut costs to bring critical research and treatments to market faster.”

 

DocuSign delivers transaction security and compliance for organizations of all sizes, in a wide-ranging number of use cases, with an end-to-end digital solution that is changing the way life sciences companies do business. USDM’s integrated solution with DocuSign includes: 

 

Validation Accelerator Pack (VAP) / Qualification Package

Vendor Audit (updated annually)

Validation Maintenance Package (updated as changes are made with new releases)

Test automation options

Subscription based services, providing the ability to maintain compliance

 

To learn more about USDM please visit http://www.usdm.com/